no statement of use filed
on 29 May 2023
Last Applicant/ Owned by
1111 Main Street
Vancouver
WA
98660
Serial Number
88787581 filed on 06th Feb 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic ste Read More
providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research and medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
No 88787581
No Service Mark
No 230042.210
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th May 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
29th May 2023 | ABANDONMENT - NO USE STATEMENT FILED |
29th Oct 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
27th Oct 2022 | SOU TEAS EXTENSION RECEIVED |
27th Oct 2022 | SOU EXTENSION 3 FILED |
27th Oct 2022 | SOU EXTENSION 3 GRANTED |
29th Apr 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
27th Apr 2022 | SOU TEAS EXTENSION RECEIVED |
27th Apr 2022 | SOU EXTENSION 2 FILED |
27th Apr 2022 | SOU EXTENSION 2 GRANTED |